CRYSTALLINE FORMS OF AN MCL-1 INHIBITOR

Disclosed herein are crystalline forms of (4S,7aR,9aR, 10R, 11E, 14S, 15R)-6'-chloro-10-methoxy-14, 15- dimethyl-10-{[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]meth yl}-3',4',7a,8,9,9a,10, 13, 14, 15-decahydro- 2'H, 3H, 5H-spiro[1,19-etheno-1616-cyclobuta[i] [1,4] oxazepino[3,...

Full description

Saved in:
Bibliographic Details
Main Authors PARENT Stephan, XIAO Lingyun, ACHMATOWICZ Michal, KELLY Ron C, REID Darren L, TENG Jing, LUU Van, CHAVES Mary, FARRELL Robert P, STEC Markian, HUCKLE James E, WU Tian
Format Patent
LanguageEnglish
Spanish
Published 15.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed herein are crystalline forms of (4S,7aR,9aR, 10R, 11E, 14S, 15R)-6'-chloro-10-methoxy-14, 15- dimethyl-10-{[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]meth yl}-3',4',7a,8,9,9a,10, 13, 14, 15-decahydro- 2'H, 3H, 5H-spiro[1,19-etheno-1616-cyclobuta[i] [1,4] oxazepino[3, 4-f] [1,2,7]thiadiazacyclohexadecine-4,1'- naphthalene]-16, 16, 18(7H, 17H)-trione (AMG 397): (AMG 397), hydrates, and solvates thereof. Also disclosed are methods of making the crystalline forms, and methods of treating diseases and disorders with the crystalline forms. Se divulgan en el presente documento formas cristalinas de (4S,7aR,9aR,10R,11E,14S,15R)-6'-cloro-10-metoxi-14,15-dimetil-10- {[(9aR)-octahidro-2H-pirido[1,2-a]pirazin-2-il]metil}-3',4',7a,8, 9,9a,10,13,14,15-decahidro-2'H,3H,5H-spiro[1,19-eteno-16l6-ciclob uta[i][1,4]oxazepino[3,4-f][1,2,7]tiadiazaciclohexadecina-4,1'-na ftaleno]-16,16,18(7H,17H)-triona (AMG 397): (AMG 397), sus hidratos y solvatos. También se divulgan métodos para fabricar las formas cristalinas y métodos para tratar enfermedades y trastornos con las formas cristalinas.
Bibliography:Application Number: MX20240009448